Developing Gene Editing Therapies That Utilize Obsidian’s cytoDRiVE™ Platform to Provide Regulated & Tunable Expression of Proteins
Time: 2:30 pm
day: Day 1- Translation 2
Details:
• Modulating the activity of gene editing tools like CRISPR-Cas9 to increase the specificity and reduce off-target effects
• Determining the best small-molecule regulators to use with the platform and validating the system in various preclinical models
• Demonstrating proof of concept for the ability to modulate gene editing activities in a controlled and precise manner
